en

PRODUCT DETAIL

Rebif 8,8 mikrogramov injekčný roztok v naplnenej injekčnej striekačke, Rebif 22 mikrogramov injekčný roztok v naplnenej injekčnej striekačke

Code 98369
MA number EU/1/98/063/007
Product Form: sol inj 6x0,2 ml /8,8 µg +6x0,5 ml/22 µg (striek.inj.napln.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Merck Europe B.V., Netherland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 Immunomodulators/-stimulants
L03A Immunostimulants
L03AB Interferons
L03AB07 Interferon beta-1a
Shelf life: 18
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 19.01.2006
SmPC + PL: European Medicines Agency's database
Dokument: DHPC interferóny final 25 8 2014.pdf  
Safety feature Yes
Data update: 19.06.2018
eu-flag.png sk-flag.png